Heterogeneity of glucocorticoid binders: a unique and a classical dexamethasone-binding site in bovine tissues.
作者信息
Do Y S, Loose D S, Feldman D
出版信息
Endocrinology. 1979 Nov;105(5):1055-63. doi: 10.1210/endo-105-5-1055.
PMID:487996
Abstract
摘要
相似文献
1
Heterogeneity of glucocorticoid binders: a unique and a classical dexamethasone-binding site in bovine tissues.
Endocrinology. 1979 Nov;105(5):1055-63. doi: 10.1210/endo-105-5-1055.
2
Is the glucocorticoid receptor identical in various target organs?
J Steroid Biochem. 1978 Feb;9(2):141-5. doi: 10.1016/0022-4731(78)90075-4.
3
Demonstration of glucocorticoid receptors in the adrenal cortex: evidence for a direct dexamethasone suppressive effect on the rat adrenal gland.
Endocrinology. 1980 Jul;107(1):137-46. doi: 10.1210/endo-107-1-137.
4
Affinity labeling of the rat liver glucocorticoid receptor with dexamethasone 21-mesylate. Identification of covalently labeled receptor by immunochemical methods.
J Biol Chem. 1981 Dec 25;256(24):12920-5.
5
Delta 1,9(11)-11-deoxycortisol: an improved glucocorticoid antagonist.
Endocrinology. 1980 Aug;107(2):472-7. doi: 10.1210/endo-107-2-472.
6
Evidence for a factor in liver cytosol which controls the competition between progesterone and triamcinolone acetonide for the glucocorticoid receptor.
Life Sci. 1977 May 1;20(9):1593-8. doi: 10.1016/0024-3205(77)90453-2.
7
Characteristics of glucocorticoid binding to mouse liver cytosol.
J Steroid Biochem. 1979 Aug;11(2):1129-34. doi: 10.1016/0022-4731(79)90163-8.
8
Heterogenetiy of glucocorticoid binders: a high affinity triamcinolone acetonide binder in bovine serum.
Endocrinology. 1980 Nov;107(5):1370-75. doi: 10.1210/endo-107-5-1370.
9
Progesterone enhances glucocorticoid dissociation from the AtT-20 cell glucocorticoid receptor.
Endocrinology. 1980 Aug;107(2):566-72. doi: 10.1210/endo-107-2-566.
10
[Evidence for the presence of glucocorticoid receptors in heart contractile cells].
Biokhimiia. 1981 Nov;46(11):1984-95.
引用本文的文献
1
Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
Drugs. 1998 Jan;55(1):145-63. doi: 10.2165/00003495-199855010-00009.
2
Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.
Drug Saf. 1996 Jun;14(6):375-85. doi: 10.2165/00002018-199614060-00003.
3
Adrenocorticoid action in the spinal cord: some unique molecular properties of glucocorticoid receptors.
Cell Mol Neurobiol. 1989 Jun;9(2):179-92. doi: 10.1007/BF00713027.
Zotero 插件